Literature DB >> 24179471

G-CSF in Healthy Allogeneic Stem Cell Donors.

Kristina Hölig1.   

Abstract

Mobilization of peripheral blood stem cells (PBSC) in healthy volunteers with granulocyte colony-stimulating factor (G-CSF) is currently carried out at many institutions worldwide. This report presents the experience of the Dresden center regarding donor evaluation and mobilization schedule. Data regarding efficacy, short- and long-term safety of G-CSF treatment gained from 8290 PBSC collections in healthy donors are outlined. These results are discussed against the background of the available evidence from the literature. Although established as a standard procedure, G-CSF application to allogeneic donors will always be a very delicate procedure and requires the utmost commitment of all staff involved to ensure maximum donor safety.

Entities:  

Keywords:  CD34+ cells; Donors; G-CSF; Hematopoietic stem cells; Leukapheresis product

Year:  2013        PMID: 24179471      PMCID: PMC3776391          DOI: 10.1159/000354196

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  77 in total

1.  Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data.

Authors:  E Azoulay; H Attalah; A Harf; B Schlemmer; C Delclaux
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

2.  Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.

Authors:  Javier de la Rubia; Cristina Arbona; Felipe de Arriba; Consuelo del Cañizo; Salut Brunet; Concha Zamora; Miguel A Díaz; Joan Bargay; José Petit; Javier de la Serna; Andrés Insunza; Rosario Arrieta; María J Pascual; David Serrano; Isabel Sanjuan; Ildefonso Espigado; Adrián Alegre; Dobleta Martínez; Amparo Verdeguer; Carmen Martínez; Luis Benlloch; Miguel A Sanz
Journal:  Transfusion       Date:  2002-01       Impact factor: 3.157

3.  Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.

Authors:  A M Cavallaro; K Lilleby; I Majolino; R Storb; F R Appelbaum; S D Rowley; W I Bensinger
Journal:  Bone Marrow Transplant       Date:  2000-01       Impact factor: 5.483

4.  Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic origin.

Authors:  Hugues de Lavallade; Patrick Ladaique; Claude Lemarié; Sabine Fürst; Catherine Faucher; Didier Blaise; Christian Chabannon; Boris Calmels
Journal:  Blood       Date:  2009-02-19       Impact factor: 22.113

5.  Peripheral blood stem cell apheresis in normal donors: the neglected side.

Authors:  P Anderlini; D Przepiorka; R Champlin; M Körbling
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

6.  Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs.

Authors:  U Platzbecker; G Prange-Krex; M Bornhäuser; R Koch; S Soucek; P Aikele; A Haack; C Haag; U Schuler; A Berndt; C Rutt; G Ehninger; K Hölig
Journal:  Transfusion       Date:  2001-02       Impact factor: 3.157

7.  Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors.

Authors:  M Murata; M Harada; S Kato; S Takahashi; H Ogawa; S Okamoto; S Tsuchiya; H Sakamaki; Y Akiyama; Y Kodera
Journal:  Bone Marrow Transplant       Date:  1999-11       Impact factor: 5.483

8.  Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  Charles L Bennett; Andrew M Evens; Leslie A Andritsos; Lakshmi Balasubramanian; Mark Mai; Matthew J Fisher; Timothy M Kuzel; Cara Angelotta; June M McKoy; Julie M Vose; Philip J Bierman; David J Kuter; Steven M Trifilio; Steven M Devine; Martin S Tallman
Journal:  Br J Haematol       Date:  2006-10-19       Impact factor: 6.998

9.  Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells.

Authors:  Arnon Nagler; Avital Korenstein-Ilan; Aliza Amiel; Lydia Avivi
Journal:  Exp Hematol       Date:  2004-01       Impact factor: 3.084

Review 10.  Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges.

Authors:  Paolo Anderlini; Richard E Champlin
Journal:  Blood       Date:  2007-12-05       Impact factor: 22.113

View more
  23 in total

1.  Hematopoietic growth factors in transfusion medicine and cellular therapy - part I.

Authors:  Peter Schlenke; Andreas Humpe
Journal:  Transfus Med Hemother       Date:  2013-08       Impact factor: 3.747

2.  Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.

Authors:  Mark A Schroeder; Michael P Rettig; Sandra Lopez; Stephanie Christ; Mark Fiala; William Eades; Fazia A Mir; Jin Shao; Kyle McFarland; Kathryn Trinkaus; William Shannon; Elena Deych; Jinsheng Yu; Ravi Vij; Keith Stockerl-Goldstein; Amanda F Cashen; Geoffrey L Uy; Camille N Abboud; Peter Westervelt; John F DiPersio
Journal:  Blood       Date:  2017-03-14       Impact factor: 22.113

Review 3.  The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span.

Authors:  Primož Rožman
Journal:  Geroscience       Date:  2018-06-14       Impact factor: 7.713

4.  Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation.

Authors:  S Bräuninger; K Thorausch; B Luxembourg; M Schulz; K U Chow; E Seifried; H Bonig
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

5.  G-CSF in stem cell mobilization: new insights, new questions.

Authors:  Andrea M Patterson; Louis M Pelus
Journal:  Ann Blood       Date:  2017-07-19

Review 6.  A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.

Authors:  B E Shaw; D L Confer; W Hwang; M A Pulsipher
Journal:  Bone Marrow Transplant       Date:  2015-01-19       Impact factor: 5.483

7.  Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor.

Authors:  Keita Yamamoto; Noriko Doki; Yasushi Senoo; Yuho Najima; Takeshi Kobayashi; Kazuhiko Kakihana; Kyoko Haraguchi; Yoshiki Okuyama; Hisashi Sakamaki; Kazuteru Ohashi
Journal:  Transfus Med Hemother       Date:  2016-10-18       Impact factor: 3.747

8.  Arachidonic acid and Docosahexanoic acid enhance platelet formation from human apheresis-derived CD34+ cells.

Authors:  Ankita Dhenge; Kedar Limbkar; Sameer Melinkeri; Vaijayanti Prakash Kale; Lalita Limaye
Journal:  Cell Cycle       Date:  2017-04-07       Impact factor: 4.534

9.  Evaluation of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in Japanese healthy donors: a prospective study.

Authors:  Keijiro Sato; Ken Ishiyama; Go Aoki; Hiroyuki Maruyama; Noriaki Tsuji; Mikoto Tanabe; Yoshitaka Zaimoku; Hidehiro Sato; Hirohito Yamazaki; Masaki Yamaguchi; Akiyoshi Takami; Shinji Nakao
Journal:  Int J Hematol       Date:  2019-09-21       Impact factor: 2.490

10.  Atraumatic idiopathic splenic rupture induced by granulocyte-colony stimulating factor (G-CSF) for the treatment of pancytopenia, managed successfully by laparoscopic splenectomy.

Authors:  Ugochukwu Chinyere Chinaka; Joshua Fultang; Jelizaveta Pereca; Abdulmajid Ali
Journal:  BMJ Case Rep       Date:  2020-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.